ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.

Attend or submit a registration, check your presentation information (including poster number), access CROI materials (eg, abstract book) for registrants. Access for registered attendees. To access the conference resources, use the same IAS–USA/CROI account login credentials that you used to register for CROI 2025.

2月24日，总部位于都柏林的CRO企业 ICON宣布将以120亿美元的股票和现金收购美国CRO 企业PRA Health Sciences。 这一价格比PRA（23日）收盘溢价30％。 合并成功后，使ICON将跃升为仅次于IQVIA的全球第二大CRO企业。 根据财报，目前全球CRO领域，PRA排名第五，ICON排名第六。 IQVIA也是2016年由IMS...

ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. [2] .

We are a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations.

ICON is a global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.

ICON可提供涵盖广泛的专业化服务，助力制药、生物科技和医疗器械公司更快地将新药和器械推向市场。 我们的服务涵盖产品开发的整个生命周期，既适用于小型本地试验，也适用于大型 …

2021年3月1日 · 2月24日，总部位于都柏林的CRO企业 ICON宣布将以120亿美元的股票和现金收购美国CRO 企业PRA Health Sciences。 这一价格比PRA（23日）收盘溢价30％。 合并成功后，使ICON将跃升为仅次于IQVIA的全球第二大CRO企业。 根据财报，目前全球CRO领域，PRA排名第五，ICON排名第六。 IQVIA也是2016年由IMS Health和Quintiles进行的170亿美元以上巨额合并产生的。 ICON首席执行官Steve Cutler在周三的电话会议上表示：“多年来，我们一直在寻 …

We are a global provider of outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations.

ICON acquires KCR, a mid-size CRO, founded and headquartered in Poland, offering full service and functional service provision clinical trial services. ICON acquires HumanFirst, a cloud …